Asian Subgroup Analysis of the Randomized Phase 3 CROWN Study of First-Line Lorlatinib Versus Crizotinib in Advanced ALK-Positive NSCLC
- Qing Zhou
- , Ross A. Soo
- , Gee Chen Chang
- , Chao Hua Chiu
- , Hidetoshi Hayashi
- , Sang We Kim
- , Shunsuke Teraoka
- , Yasushi Goto
- , Jianying Zhou
- , Victor Ho-Fun Lee
- , Dong Wan Kim
- , Baohui Han
- , James Chung Man Ho
- , Chia Chi Lin
- , Shun Lu
- , Anna Polli
- , Anna Maria Calella
- , Jean François Martini
- , Chew Hooi Wong
- , Tony Mok
Research output: Contribution to journal › Article › peer-review
10
Link opens in a new tab
Citations
(Scopus)